Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
2
×
ally bridge group
azacitidine
beta-thalassemia
big data analytics
blackrock
casdin capital
clinical trials
dacogen
deals
decitabine
diabetic nephropathy
dna
epigenetics
epizyme
eventide asset management
farydak
flagship pioneering
focal segmental glomerulosclerosis
fulcrum therapeutics
goldfinch bio
insulated genomic domains
irving investors
jay ghosh
kaleido biosciences
mahesh karande
new york blog main
new york top stories
omega therapeutics
panobinostat
richard young
robert gould
rudolf jaenisch
san francisco blog main
What
biotech
2
×
medicines
new
aims
analysis
approach
based
bio
bring
called
company
debuts
develop
developing
diseases
drug
drugs
employing
epigenetic
epigenetics
field
flagship’s
genetic
goldfinch
ipo
kidney
later
lead
million
morning
omega
raised
raises
research
startup
step
studies
therapeutics
touting
Language
unset
Current search:
biotech
×
boston
×
" national top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further